Amedisys, Inc. (AMED) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Amedisys, Inc. (AMED) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 50/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Amedisys, Inc. (AMED) Resumen de Asistencia Médica y Tuberías
Amedisys, Inc. is a healthcare provider specializing in home health, hospice, personal care, and high acuity services across 38 states and the District of Columbia. With a market capitalization of $3.32 billion and a P/E ratio of 22.16, Amedisys addresses the growing demand for in-home healthcare solutions.
Tesis de Inversión
Amedisys presents a compelling investment case based on its established market presence and diversified service offerings within the growing home healthcare sector. The company's focus on home health and hospice care aligns with the increasing demand for cost-effective and patient-centric healthcare solutions. With a market capitalization of $3.32 billion and a profit margin of 6.2%, Amedisys demonstrates financial stability. Growth catalysts include expanding its high acuity care services and leveraging its existing infrastructure to penetrate new geographic markets. Potential risks include regulatory changes and increased competition from other home healthcare providers. The company's beta of 0.90 suggests moderate volatility relative to the market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $3.32 billion indicates a strong market valuation.
- P/E ratio of 22.16 suggests a moderate valuation relative to earnings.
- Profit margin of 6.2% reflects profitability within the healthcare services sector.
- Gross margin of 52.3% demonstrates efficient cost management.
- Presence in 38 states and the District of Columbia provides a broad geographic footprint.
Competidores y Pares
Fortalezas
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Extensive network of care centers and healthcare professionals.
- Established relationships with hospitals and healthcare systems.
- Strong brand reputation and market presence.
Debilidades
- Exposure to regulatory changes and reimbursement pressures.
- Competition from other home healthcare providers.
- Dependence on government funding and reimbursement policies.
- Potential for staffing shortages and labor cost increases.
Catalizadores
- Ongoing: Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Ongoing: Geographic expansion into underserved markets.
- Ongoing: Strategic acquisitions to expand service offerings and market reach.
- Ongoing: Leveraging technology to improve operational efficiency and enhance patient care.
Riesgos
- Potential: Changes in government regulations and reimbursement policies.
- Ongoing: Increased competition from other home healthcare providers.
- Potential: Economic downturns and reduced healthcare spending.
- Potential: Cybersecurity threats and data breaches.
Oportunidades de crecimiento
- Growth opportunity 1: Expansion of High Acuity Care Services: Amedisys can capitalize on the increasing demand for hospital-at-home models by expanding its High Acuity Care segment. This involves delivering acute medical care in patients' homes, reducing the need for hospital stays and lowering healthcare costs. The market for hospital-at-home services is projected to reach billions of dollars in the coming years, presenting a significant growth opportunity for Amedisys. Timeline: Ongoing.
- Growth opportunity 2: Geographic Expansion: Amedisys can expand its presence in underserved markets by establishing new care centers and acquiring existing providers. This involves identifying regions with a high demand for home health, hospice, and personal care services and developing a strategic plan for market entry. Geographic expansion can drive revenue growth and increase Amedisys's market share. Timeline: Ongoing.
- Growth opportunity 3: Strategic Acquisitions: Amedisys can pursue strategic acquisitions to expand its service offerings and geographic reach. This involves identifying companies with complementary services or a strong presence in key markets and integrating them into Amedisys's operations. Strategic acquisitions can accelerate growth and enhance Amedisys's competitive position. Timeline: Ongoing.
- Growth opportunity 4: Technology Adoption: Amedisys can leverage technology to improve operational efficiency, enhance patient care, and reduce costs. This involves implementing telehealth solutions, remote monitoring devices, and data analytics tools to streamline workflows and improve patient outcomes. Technology adoption can drive innovation and create a competitive advantage for Amedisys. Timeline: Ongoing.
- Growth opportunity 5: Partnerships with Healthcare Systems: Amedisys can form partnerships with hospitals and healthcare systems to provide integrated care solutions. This involves collaborating with healthcare providers to deliver seamless transitions of care from hospitals to patients' homes, reducing hospital readmissions and improving patient satisfaction. Partnerships can drive referrals and increase Amedisys's patient volume. Timeline: Ongoing.
Oportunidades
- Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Geographic expansion into underserved markets.
- Strategic acquisitions to expand service offerings and market reach.
- Leveraging technology to improve operational efficiency and enhance patient care.
Amenazas
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns and reduced healthcare spending.
- Cybersecurity threats and data breaches.
Ventajas competitivas
- Established market presence and brand recognition.
- Extensive network of care centers and healthcare professionals.
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Strong relationships with hospitals and healthcare systems.
Acerca de AMED
Amedisys, Inc., founded in 1982 and headquartered in Baton Rouge, Louisiana, provides a range of healthcare services across the United States. The company operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment focuses on delivering skilled nursing, rehabilitation therapy, and social services to patients recovering from surgery, managing chronic conditions, or facing terminal illnesses. This segment aims to reduce hospital readmissions and improve patient outcomes through in-home care. The Hospice segment offers comfort and support to individuals dealing with terminal illnesses such as cancer, heart disease, pulmonary disease, and Alzheimer's. The Personal Care segment provides assistance with daily living activities, enabling patients to maintain independence and quality of life. The High Acuity Care segment delivers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, Amedisys owned and operated 331 home health care centers, 175 hospice care centers, 14 personal-care centers, and 8 high acuity care centers across 38 states and the District of Columbia. Amedisys's comprehensive service offerings and extensive geographic reach position it as a significant player in the evolving healthcare landscape.
Qué hacen
- Provides home health services, including skilled nursing and rehabilitation therapy.
- Offers hospice care for patients with terminal illnesses.
- Delivers personal care services to assist with daily living activities.
- Provides high acuity care services, bringing hospital-level care to patients' homes.
- Operates a network of care centers across 38 states and the District of Columbia.
- Focuses on improving patient outcomes and reducing hospital readmissions.
Modelo de Negocio
- Generates revenue through providing home health, hospice, personal care, and high acuity care services.
- Receives payments from Medicare, Medicaid, private insurance, and individual patients.
- Operates a network of care centers and employs healthcare professionals to deliver services.
- Focuses on managing costs and improving operational efficiency to maximize profitability.
Contexto de la Industria
Amedisys operates within the expanding medical care facilities industry, driven by an aging population and a growing preference for in-home healthcare services. The industry is characterized by increasing demand for home health, hospice, and personal care services. Key competitors include LHC Group (LHCG) and AccentCare, reflecting a fragmented market with opportunities for consolidation and expansion. The industry is subject to regulatory oversight and reimbursement policies, which impact revenue and profitability.
Clientes Clave
- Individuals recovering from surgery or managing chronic conditions.
- Patients with terminal illnesses requiring hospice care.
- Individuals needing assistance with daily living activities.
- Hospitals and healthcare systems seeking to reduce readmissions and improve patient outcomes.
Finanzas
Gráfico e información
Precio de la acción de Amedisys, Inc. (AMED): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Monday
benzinga · 10 oct 2022
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · 29 sept 2022
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · 14 jun 2022
-
Stocks That Hit 52-Week Lows On Monday
· 23 ago 2021
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para AMED.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para AMED.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de AMED en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Liderazgo: Richard M. Ashworth
CEO
Richard M. Ashworth serves as the CEO of Amedisys, Inc. His career spans various leadership roles within the healthcare industry. Ashworth brings extensive experience in healthcare management, strategic planning, and operational execution. Prior to joining Amedisys, he held executive positions at leading healthcare organizations, where he focused on driving growth, improving patient outcomes, and enhancing operational efficiency. His expertise in healthcare delivery and business development positions him to lead Amedisys in a dynamic and competitive market.
Historial: Under Richard M. Ashworth's leadership, Amedisys has focused on expanding its high acuity care services and leveraging technology to improve patient care. He has overseen strategic initiatives to enhance operational efficiency and drive revenue growth. Key milestones include expanding the company's geographic footprint and strengthening its relationships with hospitals and healthcare systems.
Lo Que los Inversores Preguntan Sobre Amedisys, Inc. (AMED)
¿Cuáles son los factores clave para evaluar AMED?
Amedisys, Inc. (AMED) actualmente tiene una puntuación IA de 50/100, indicando puntuación moderada. Fortaleza clave: Diversified service offerings across home health, hospice, personal care, and high acuity care.. Riesgo principal a monitorear: Potential: Changes in government regulations and reimbursement policies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de AMED?
AMED actualmente puntúa 50/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de AMED?
Los precios de AMED se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre AMED?
La cobertura de analistas para AMED incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en AMED?
Las categorías de riesgo para AMED incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in government regulations and reimbursement policies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de AMED?
La relación P/E para AMED compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está AMED sobrevalorada o infravalorada?
Determinar si Amedisys, Inc. (AMED) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de AMED?
Amedisys, Inc. (AMED) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.